Adrián LLerena

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>CYP2D6</i> and <i>CYP2C19</i> Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors

J K Hicks, JR Bishop, Katrin Sangkuhl et al. · Clinical Pharmacology & Therapeutics · 2015 · 975 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test.

Leif Bertilsson, JA Carrillo, M-L Dahl et al. · British Journal of Clinical Pharmacology · 1994 · 308 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels

José de León, Georgios Schoretsanitis, Robert L. Smith et al. · Pharmacopsychiatry · 2021 · 259 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Pharmacokinetics of losartan and its metabolite E‐3174 in relation to the <i>CYP2C9</i> genotype

Ümit Yaşar, Cecilia Forslund‐Bergengren, Gunnel Tybring et al. · Clinical Pharmacology & Therapeutics · 2002 · 183 citations

Medicine, Pharmacokinetics, Pharmacology +11

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>CYP2C9</i> and <i>HLA‐B</i> Genotypes and Phenytoin Dosing: 2020 Update

Jason H. Karnes, Allan E. Rettie, Andrew A. Somogyi et al. · Clinical Pharmacology & Therapeutics · 2020 · 171 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17